Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
01/05/1995 | WO1995000654A1 Mesothelial cell gene therapy |
01/05/1995 | WO1995000653A1 Synthetic antifungal peptides |
01/05/1995 | WO1995000652A1 Chimeric plant genes possessing independent regulatory sequences |
01/05/1995 | WO1995000651A1 Recombinant stratum corneum chymotryptic enzyme (scce) |
01/05/1995 | WO1995000650A1 Recombinant dnase b derived from streptococcus pyogenes |
01/05/1995 | WO1995000649A1 Lipoprotein associated phospholipase a2, inhibitors thereof and use of the same in diagnosis and therapy |
01/05/1995 | WO1995000648A1 Nucleic acids of a novel hantavirus and reagents for detection and prevention of infection |
01/05/1995 | WO1995000647A1 Toxin gene from xenorhabdus nematophilus |
01/05/1995 | WO1995000646A1 Interleukin-3 (il-3) human/murine hybrid polypeptides |
01/05/1995 | WO1995000645A2 Process for producing relaxin |
01/05/1995 | WO1995000644A1 Vectors for genetically engineered cells that produce insulin in response to glucose |
01/05/1995 | WO1995000643A2 Human cell adhesion protein aamp-1 and uses thereof |
01/05/1995 | WO1995000642A1 Vertebrate apoptosis gene: compositions and methods |
01/05/1995 | WO1995000641A1 Lipopolysaccharide binding protein derivatives |
01/05/1995 | WO1995000640A1 Cloning and recombinant production of crf (corticotropin releasing factor) receptor(s) |
01/05/1995 | WO1995000639A1 Clostridium bifermentans dna fragment bearing genes coding for proteins linked to an insecticidal activity |
01/05/1995 | WO1995000638A2 Antisense oligonucleotides and therapeutic use thereof in human immunodeficiency virus infection |
01/05/1995 | WO1995000637A1 Transgenic production of ec-sod |
01/05/1995 | WO1995000636A1 A fungal protein disulfide isomerase |
01/05/1995 | WO1995000635A1 Liquid detergent compositions containing cellulase and amine |
01/05/1995 | WO1995000634A1 Chrysanthemyl diphosphate synthase, corresponding genes and use in pyrethrin synthesis |
01/05/1995 | WO1995000633A2 Construction and use of synthetic constructs encoding syndecan |
01/05/1995 | WO1995000555A1 Regulation of site-specific recombination by site-specific recombinase/nuclear receptor fusion proteins |
01/05/1995 | WO1995000552A1 Prostaglandin receptor ep3 and dna encoding it |
01/05/1995 | WO1995000551A1 Prostaglandin receptor fp and dna encoding it |
01/05/1995 | WO1995000547A1 Antimicrobial composition of a polymer and a peptide forming amphiphilic helices of the magainin-type |
01/05/1995 | WO1995000530A1 Hybridization and sequencing of nucleic acids |
01/05/1995 | WO1995000529A1 INHIBITION OF INTERFERON-η WITH OLIGONUCLEOTIDES |
01/05/1995 | WO1995000528A1 Inhibition of basic fibroblast growth factor with oligonculeotides |
01/05/1995 | WO1995000309A1 Method of manufacturing cylindrical body |
01/05/1995 | WO1995000160A1 Programmed cell death genes and proteins |
01/05/1995 | WO1995000159A1 Isolated peptides which form complexes with mhc molecule hla-c-clone 10 and uses thereof |
01/05/1995 | WO1995000103A2 Anti-sense oligodeoxynucleotide to fibrogenic cytokines and use thereof |
01/05/1995 | WO1994026922A3 Methods and compositions relating to sterol regulatory element binding proteins |
01/05/1995 | WO1994026913A3 Marker gene |
01/05/1995 | WO1994025612A3 Nucleotide sequences for the control of the expression of dna sequences in a cellular host |
01/05/1995 | WO1994023059A3 Anti-microbial agents and screening method therefor |
01/05/1995 | WO1994023049A3 The introduction and expression of large genomic sequences in transgenic animals |
01/05/1995 | WO1994023041A3 Method for selective inactivation of viral replication |
01/05/1995 | WO1994021801A3 Purification and molecular cloning of eg iii cellulase |
01/05/1995 | WO1994021792A3 Inhibition of selected tumor growth with recombinant viral vectors |
01/05/1995 | WO1994018324A3 Phospho-specific antibodies against transcription factors, more specifically against a creb derived peptide |
01/05/1995 | WO1994010288A3 Medium-chain thioesterases in plants |
01/05/1995 | DE4405841C1 Multipotent non-specific immunity inducers based on combinations of poxvirus components, processes for their preparation and their use as pharmaceuticals |
01/05/1995 | DE4318186A1 Retrovirus from HIV group and use thereof |
01/05/1995 | CA2166124A1 Clostridium bifermentans dna fragment bearing genes coding for proteins linked to an insecticidal activity |
01/05/1995 | CA2166104A1 Nucleic acids of a novel hantavirus and reagents for detection and prevention of infection |
01/05/1995 | CA2166078A1 Vectors for genetically engineered cells that produce insulin in response to glucose |
01/05/1995 | CA2165986A1 Synthetic antifungal peptides |
01/05/1995 | CA2165797A1 Monoclonal antibodies against the alpha pdgf receptor and uses thereof |
01/05/1995 | CA2165777A1 Programmed cell death genes and proteins |
01/05/1995 | CA2165559A1 Human cell adhesion protein aamp-1 and uses thereof |
01/05/1995 | CA2165545A1 Improved methods for detecting nucleic acid sequences |
01/05/1995 | CA2165544A1 Improved nucleic acid reactions |
01/05/1995 | CA2165461A1 Compositions and diagnostic methods using monoclonal antibodies against cd44v6 |
01/05/1995 | CA2165163A1 Thermodynamics, design, and use of nucleic acid sequences |
01/05/1995 | CA2165053A1 Linear and branched peptides effective in diagnosing and detecting non-a, non-b hepatitis |
01/05/1995 | CA2164728A1 Processes for diagnosing and analysing tumours |
01/05/1995 | CA2164715A1 Parallel primer extension approach to nucleic acid sequence analysis |
01/05/1995 | CA2164424A1 Mesothelial cell gene therapy |
01/05/1995 | CA2164089A1 Transgenic production of ec-sod |
01/05/1995 | CA2162925A1 Chimeric plant genes possessing independent regulatory sequences |
01/05/1995 | CA2162485A1 Toxin gene from xenorhabdus nematophilus |
01/05/1995 | CA2141535A1 Recombinant dnase b derived from streptococcus pyogenes |
01/04/1995 | EP0632134A2 Reagents and methods for coupled high temperature reverse transcription and polymerase chain reaction |
01/04/1995 | EP0632129A1 Recombinant foamy virus vectors for medicinal and diagnostic uses, and processes for preparing recombinant foamy virus vectors |
01/04/1995 | EP0632128A1 Novel plant gene |
01/04/1995 | EP0632054A1 Regulation of site-specific recombination by site-specific recombinase/nuclear receptor fusion proteins |
01/04/1995 | EP0631636A1 Exchangeable template reaction |
01/04/1995 | EP0631635A1 Comparative genomic hybridization (cgh) |
01/04/1995 | EP0631633A1 Reaction-based selection for expression of and concentration of catalytic moieties |
01/04/1995 | EP0631631A1 A process for producing heme proteins |
01/04/1995 | EP0631630A1 Control of male fertility using externally inducible promoter sequences |
01/04/1995 | EP0631629A1 Fungus-responsive chimaeric gene |
01/04/1995 | EP0631628A1 Transgenic wheat |
01/04/1995 | EP0631627A1 A method for production of proteins in yeast |
01/04/1995 | EP0631626A1 Thermosensitive plasmid |
01/04/1995 | EP0631625A1 Improvements in or relating to dna cloning techniques and products for use therewith |
01/04/1995 | EP0631624A1 Receptor complexes with b29 (ig-beta or ig-gamma) and their uses |
01/04/1995 | EP0631623A1 Dna encoding taurine and gaba transporters and uses thereof |
01/04/1995 | EP0631620A1 Selection methods |
01/04/1995 | EP0631618A1 Culturing of hematopoietic stem cells and their genetic engineering |
01/04/1995 | EP0631507A1 Selective alteration of antibody immunogenicity |
01/04/1995 | EP0631506A1 Selectively deglycosylated human immunodeficiency virus type 1 envelope vaccines |
01/04/1995 | EP0567576B1 Treatment of neoplastic disease with interleukin-10 |
01/04/1995 | EP0546045B1 Enzymes with xylanolytic activity |
01/04/1995 | EP0514405B1 Strain ral-4, useful for production of small proteins and peptides |
01/03/1995 | US5378824 Nucleic acid fragment encoding herbicide resistant plant acetolactate synthase |
01/03/1995 | US5378823 Trophoblastin |
01/03/1995 | US5378821 Isolated from tolypocladium; fungicides, insecticides |
01/03/1995 | US5378819 Nucleic acid or DNA for genetic engineering |
01/03/1995 | US5378814 Hepatitis delta viral polypeptides |
01/03/1995 | US5378812 Human antibodies which specifically bind to lipopolysaccharide determinants of some pseudomonas serotypes and inhibit these bacteria, for prevention and treatment of infections |
01/03/1995 | US5378809 Polynucleotides and substrate for the epidermal growth factor receptor kinase (eps8) |
01/03/1995 | US5378808 Isolated DNA sequence; anemia; genetic engineering |
01/03/1995 | US5378806 Genetic engineering |
01/03/1995 | US5378625 Bacillus thuringiensis cryIIIC, (b) protein toxic to coleopteran insects |
01/03/1995 | US5378620 Streptolysin O derivatives |
01/03/1995 | US5378619 Promoter from figwort mosaic virus |
01/03/1995 | US5378618 Vitro headful packaging system for cloning DNA fragments as large as 95kb |